1. Home
  2. TPCS vs ICCC Comparison

TPCS vs ICCC Comparison

Compare TPCS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • ICCC
  • Stock Information
  • Founded
  • TPCS 1956
  • ICCC 1982
  • Country
  • TPCS United States
  • ICCC United States
  • Employees
  • TPCS N/A
  • ICCC N/A
  • Industry
  • TPCS Metal Fabrications
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPCS Industrials
  • ICCC Health Care
  • Exchange
  • TPCS Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • TPCS 42.6M
  • ICCC 46.2M
  • IPO Year
  • TPCS N/A
  • ICCC 1987
  • Fundamental
  • Price
  • TPCS $3.75
  • ICCC $6.39
  • Analyst Decision
  • TPCS
  • ICCC
  • Analyst Count
  • TPCS 0
  • ICCC 0
  • Target Price
  • TPCS N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • TPCS 68.2K
  • ICCC 25.6K
  • Earning Date
  • TPCS 04-08-2025
  • ICCC 05-14-2025
  • Dividend Yield
  • TPCS N/A
  • ICCC N/A
  • EPS Growth
  • TPCS N/A
  • ICCC N/A
  • EPS
  • TPCS N/A
  • ICCC N/A
  • Revenue
  • TPCS $33,154,058.00
  • ICCC $27,302,766.00
  • Revenue This Year
  • TPCS N/A
  • ICCC N/A
  • Revenue Next Year
  • TPCS N/A
  • ICCC N/A
  • P/E Ratio
  • TPCS N/A
  • ICCC N/A
  • Revenue Growth
  • TPCS 8.71
  • ICCC 28.29
  • 52 Week Low
  • TPCS $2.05
  • ICCC $3.34
  • 52 Week High
  • TPCS $4.42
  • ICCC $6.84
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 59.62
  • ICCC 68.80
  • Support Level
  • TPCS $3.75
  • ICCC $6.00
  • Resistance Level
  • TPCS $4.00
  • ICCC $6.57
  • Average True Range (ATR)
  • TPCS 0.28
  • ICCC 0.39
  • MACD
  • TPCS -0.04
  • ICCC 0.09
  • Stochastic Oscillator
  • TPCS 46.83
  • ICCC 78.16

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: